Fred Aslan
Chief Executive Officer at Artiva Biotherapeutics · 14 reported transactions in 1 company · latest trade Oct 6, 2026
Their trades
Sold | Oct 6, 2026 | Oct 6, 2026 close $7.27 → Oct 29, 2026 close $4.23. S&P 500 −1.3% over the same days. | ||
Sold | Oct 5, 2026 | Oct 5, 2026 close $7.13 → Oct 29, 2026 close $4.23. S&P 500 −0.7% over the same days. | ||
Sold | May 19, 2026 | May 19, 2026 close $8.55 → Oct 29, 2026 close $4.23. S&P 500 +4.9% over the same days. | ||
Sold | Dec 15, 2025 | Dec 15, 2025 close $6.30 → Oct 29, 2026 close $4.23. S&P 500 +13.0% over the same days. | ||
Sold | Nov 17, 2025 | Nov 17, 2025 close $3.51 → Oct 29, 2026 close $4.23. S&P 500 +15.6% over the same days. |
$168.9K
Oct 6, 2026 close $7.27 → Oct 29, 2026 close $4.23. S&P 500 −1.3% over the same days.
$421.8K
Oct 5, 2026 close $7.13 → Oct 29, 2026 close $4.23. S&P 500 −0.7% over the same days.
$244.3K
May 19, 2026 close $8.55 → Oct 29, 2026 close $4.23. S&P 500 +4.9% over the same days.
$19.1K
Dec 15, 2025 close $6.30 → Oct 29, 2026 close $4.23. S&P 500 +13.0% over the same days.
$21.5K
Nov 17, 2025 close $3.51 → Oct 29, 2026 close $4.23. S&P 500 +15.6% over the same days.